3.0
1 Oct 2019
Former employee, more than 5 years
Recommend
CEO approval
Business outlook
Pros
The people, the vacation policy
Cons
They tout how they have mountains of cash and no debt but one by one their products are losing exclusivity therefore they have less and less need for reps as their portfolio shrinks. The culture is also changing from an employee favorable to the quintessential American big pharma of "what have you done lately"